RxDoctor Payments DataLook up a doctor →

Candyce Brown, APRN

Psychiatric/Mental Health · Lake Charles, LANPI 1598227779

Payments from drug & device makers

$12,704in general payments, 2019–2025

Across 735 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Otsuka America Pharmaceutical, Inc.$2K
  • Alkermes, Inc.$1K
  • Neurocrine Biosciences, Inc.$1K
  • Johnson & Johnson$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$769
  • plus $5K from 23 others

What the payments were for

  • Food & beverage$12,699100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,704 in reported general payments places this provider in the 95th percentile of 615 psychiatric/mental health providers in Louisiana.

See all psychiatric/mental health providers in Louisiana

Medicare billing

Part B allowed, 2024
$11,628
Medicare patients
26
Services billed
115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lurasidone Hcl18$4,874
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine65$1,603
Aripiprazole66$1,508
Duloxetine Hcl72$1,133
Divalproex Sodium ErDivalproex Sodium24$677
Mirtazapine48$534
Desvenlafaxine Succinate ErDesvenlafaxine Succinate17$484
Sertraline Hcl49$417
Trazodone Hcl75$391
Bupropion XlBupropion Hcl29$379
Olanzapine31$363
Buspirone Hcl47$361
Alprazolam77$328
Clonazepam54$296
Diazepam42$294

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Lake Charles

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →